WARM AUTOIMMUNE HEMOLYTIC ANEMIA

Clinical trials for WARM AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.

Never miss a new study

Get alerted when new WARM AUTOIMMUNE HEMOLYTIC ANEMIA trials appear

Sign up with your email to follow new studies for WARM AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

Second chance: drug retrial offers hope for patients whose blood disorder returned

Disease control Recruiting now

This study is testing whether a second course of the drug ianalumab can safely help control two rare blood disorders—ITP and wAIHA—in adults who benefited from it before but later relapsed. It will enroll about 60 people who previously participated in related ianalumab trials. Th…

Matched conditions: WARM AUTOIMMUNE HEMOLYTIC ANEMIA

Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

WARM AUTOIMMUNE HEMOLYTIC ANEMIA

Get alerted when new WARM AUTOIMMUNE HEMOLYTIC ANEMIA trials appear

Second chance: drug retrial offers hope for patients whose blood disorder returned